ADANX | CVSOX | ADANX / CVSOX | |
Total Expense Ratio | 2.12 | 0.89 | 238% |
Annual Report Gross Expense Ratio | 2.12 | 0.89 | 238% |
Fund Existence | 17 years | 5 years | - |
Gain YTD | 5.533 | 5.040 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.95B | 16.7B | 12% |
Annual Yield % from dividends | 0.91 | 1.98 | 46% |
Returns for 1 year | 5.42 | 7.66 | 71% |
Returns for 3 years | 11.87 | 19.17 | 62% |
Returns for 5 years | 32.29 | 21.22 | 152% |
Returns for 10 years | 74.33 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBDW | 21.25 | 0.05 | +0.24% |
iShares iBonds Dec 2031 Term Corp ETF | |||
QBUF | 28.35 | 0.02 | +0.07% |
Innovator Nasdaq-100 10 Buffr ETF - Qt | |||
PSMR | 29.03 | N/A | -0.01% |
Pacer Swan SOS Moderate (April) ETF | |||
INDE | 29.59 | N/A | -0.01% |
Matthews India Active ETF | |||
DJAN | 41.54 | -0.03 | -0.07% |
FT Vest US Equity Dp Bffr ETF Jan |